Neuroscience
Glucocorticoid
100%
Stem Cell
100%
T Cell
100%
Asparaginase
100%
Intrathecal
100%
Vincristine
100%
Methotrexate
100%
RUNX1
100%
ETV6
100%
Keyphrases
Acute Lymphoblastic Leukemia
100%
Older Adolescents
100%
Improved Prognosis
100%
Young Patients
50%
Event-free Survival
25%
Total Therapy
25%
High-risk Population
12%
Overall Survival
12%
Older Adults
12%
Minimal Residual Disease
12%
Stem Cell Transplantation
12%
Remission Induction
12%
Residual Disease
12%
L-asparaginase
12%
Methotrexate
12%
Intrathecal Drug Delivery
12%
Leukemic Cells
12%
High-risk Acute Leukemia
12%
Pediatric Patients
12%
ETV6-RUNX1
12%
Clinical Features
12%
Intensive Chemotherapy
12%
Risk-adjusted
12%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
12%
Overall Survival Rate
12%
Survival Rate
12%
Treatment Selection
12%
Adolescent Age
12%
MLL4
12%
Nursing and Health Professions
Adolescent
100%
Acute Lymphoblastic Leukemia
100%
Survival Rate
28%
Overall Survival
28%
Event Free Survival
28%
Minimal Residual Disease
28%
High Risk Population
14%
Pediatrics Patient
14%
Remission
14%
Glucocorticoid
14%
Clinical Feature
14%
Vincristine
14%
Methotrexate
14%
Asparaginase
14%
Stem Cell Therapy
14%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Adolescence
100%
Minimal Residual Disease
25%
Event Free Survival
25%
Overall Survival
25%
Survival Rate
25%
High Risk Population
12%
Vincristine
12%
Glucocorticoid
12%
Spontaneous Remission
12%
Pediatrics Patient
12%
Stem Cell Therapy
12%
Asparaginase
12%
Clinical Feature
12%
Methotrexate
12%
Chemotherapy
12%
Biochemistry, Genetics and Molecular Biology
Adolescence
100%
Event Free Survival
25%
Overall Survival
25%
Survival Rate
25%
High Risk Population
12%
T Cell
12%
Stem Cell Transplantation
12%
ETV6
12%
Asparaginase
12%
RUNX1
12%
Cell Genetics
12%
Glucocorticoid
12%
Methotrexate
12%